Andree Yeramian Hakim
Grado: Doctor/a
973 70 36 67
andree.yeramian(ELIMINAR)@udl.cat
ResearcherID: http://www.researcherid.com/rid/B-5936-2009
Publicaciones
-
Sanchez, E; Betriu, A; Yeramian, A; Fernandez, E; Purroy, F; Sanchez-de-la-Torre, M; Pamplona, R; Miquel, E; Kerkeni, M; Hernandez, C; Simo, R; Lecube, A; Hernandez, M; Rius, F; Polanco, D; Barbe, F; Torres, G; Suarez, G; Portero-Otin, M; Jove, M; Colas-Campas, L; Benabdelhak, I; Farras, C; Ortega, M; Valdivielso, JM; Bermudez-Lopez, M; Martinez-Alonso, M; ILERVAS Project
Skin Autofluorescence Measurement n Subclinical Atheromatous Disease: Results from the ILERVAS Project
Journal of Atherosclerosis and Thrombosis 26 879-889. .
-
Lopez-Cano, C; Rius, F; Sanchez, E; Gaeta, AM; Betriu À; Fernandez, E; Yeramian, A; Hernandez, M; Bueno, M; Gutierrez-Carrasquilla, L; Dalmases, M; Lecube, A
The influence of sleep apnea syndrome and intermittent hypoxia in carotid adventitial vasa vasorum
PLOS ONE 14 -. .
-
Rius, F; Sanchez, E; Betriu À; Baena-Fustegueras, JA; Yeramian, A; Vidal, T; Hernandez, M; Lopez-Cano, C; Bueno, M; Gutierrez-Carrasquilla, L; Herrerias, F; de la Fuente, MC; Fernandez, E; Lecube, A
Influence of Morbid Obesity and Bariatric Surgery Impact on the Carotid Adventitial Vasa Vasorum Signal
OBESITY SURGERY 28 3935-3942. .
-
Nager, M; Sallan, MC; Visa, A; Pushparaj, C; Santacana, M; Macia, A; Yeramian, A; Canti, C; Herreros, J
Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers
Autophagy 14 619-636. .
-
Eritja, N; Felip, I; Dosil, MA; Vigezzi, L; Mirantes, C; Yeramian, A; Navaridas, R; Santacana, M; Llobet-Navas, D; Yoshimura, A; Nomura, M; Encinas, M; Matias-Guiu, X; Dolcet, X
A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-beta in mouse endometrium
CELL DEATH AND DIFFERENTIATION 24 1443-1458. .
-
Eritja, N; Chen, BJ; Rodriguez-Barrueco, R; Santacana, M; Gatius, S; Vidal, A; Marti, MD; Ponce, J; Bergada, L; Yeramian, A; Encinas, M; Ribera, J; Reventos, J; Boyd, J; Villanueva, A; Matias-Guiu, X; Dolcet, X; Llobet-Navas, D
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer
Autophagy 13 608-624. .
-
Eritja, N; Yeramian, A; Chen, BJ; Llobet-Navas, D; Ortega, E; Colas, E; Abal, M; Dolcet, X; Reventos, J; Matias-Guiu, X
Endometrial Carcinoma: Specific Targeted Pathways
Advances in Experimental Medicine and Biology 943 149-207. .
-
Jonsson, M; Ragnum, HB; Julin, CH; Yeramian, A; Clancy, T; Frikstad, KAM; Seierstad, T; Stokke, T; Matias-Guiu, X; Ree, AH; Flatmark, K; Lyng, H
Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition
BRITISH JOURNAL OF CANCER 115 929-939. .
-
Jove, M; Gatius, S; Yeramian, A; Portero-Otin, M; Eritja, N; Santacana, M; Colas, E; Ruiz, M; Pamplona, R; Matias-Guiu, X
Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism
Oncotarget 7 52364-52374. .
-
Yeramian A; García V; Bergadà L; Domingo M; Santacana M; Valls J; Martinez-Alonso M; Carceller JA; Cussac AL; Dolcet X; Matias-Guiu X
Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-kappa B Pathway in Endometrial Cancer
MOLECULAR IMAGING AND BIOLOGY 18 545-556. .
-
Yeramian, A; Vea, A; Benitez, S; Ribera, J; Domingo, M; Santacana, M; Martinez, M; Maiques, O; Valls, J; Dolcet, X; Vilella, R; Cabiscol, E; Matias-Guiu, X; Marti, RM
2-phenylethynesulphonamide (PFT-) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels
PIGMENT CELL & MELANOMA RESEARCH 29 352-371. .
-
Bergadà L; Yeramian A; Sorolla A; Matias-Guiu X; Dolcet X
Antioxidants Impair Anti-Tumoral Effects of Vorinostat, but Not Anti-Neoplastic Effects of Vorinostat and Caspase-8 Downregulation
PLOS ONE 9 -. .
Proyectos
- ¿CONOCER LA PREDISPOSICION GENETICA DEL PACIENTE CON OBESIDAD AYUDA A MEJORAR LA EFICACIA DE LA CIRUGÍA BARIÁTRICA?
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- La serine/threonine protein kinase PRK1 en l'adipòcit de pacients amb diabetes (Ajut per a la recerca de la Societat Catalana d'Endocrinologia i Nutrició)
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UN DOCTOR PER LA REALITZACIO DE L'ESTUDI DE LA FUNCIO PULMONAR I LA RESPIRACIO DURANT LA NIT: DUES NOVES PREOCUPACIONS PER LA DIABETIS MELLITUS TIPUS 2.
- ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment
- Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares
- EXPRESION DE CANALES DE CALCIO DE TIPO T EN NEOPLASIAS MELANOCÍTICAS BENIGNAS Y MALIGNAS. EVALUACION DE SU APLICICABILIDAD CLINICA COMO DIANAS TERAPEUTICAS EN EL MELANOMA
- Alteraciones moleculares relacionados con la progresión tumoral en el cáncer de endometrio
- MECANISMOS DE REGULACION FLIP Y LA RESPUESTA A TRAIL EN EL DESARROLLO Y PROGRESION DEL CANCER
- Caracterización de las células neoplásicas inmaduras pluripotenciales (células madre neoplásicas) en el cáncer de endometrio. Implicaciones Patogénicas, pronósticas y terapeuticas
